CELCUITY INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.76 USD | -5.10% |
|
-0.42% | +15.03% |
| May. 16 | Craig-Hallum Adjusts Price Target on Celcuity to $27 From $25, Assumes Buy Rating | MT |
| May. 16 | Celcuity Q1 Net Loss Widens; Shares Rise After Hours | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CELCUITY INC. | Bio Therapeutic Drugs | -5.10% | -0.42% | +15.03% | +67.18% | -25.84% | 552M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- CELC Stock
- Charts Celcuity Inc.
- Comparison Chart
